Developing an analytical procedure with “the end in mind” can be successfully obtained by applying a structured and systematic approach.

Data is the raw material of decisions and claims we make and, in modern society, the basis for being considered good practitioners on actions that others can observe.

USP and BP Pharmacopeias recently announced new General Chapters. You will also learn how Empower Method Validation Manager (MVM) continues to be the perfect tool for this new validation guideline.

Organic pigments are characterized by laser desorption ionization-trapped ion mobility spectrometry-time of flight-mass spectrometry (LDI-timsTOF-MS) imaging.

We present highly sensitive HCP identifications using NIST mAb reference material as sample. A high number of protein identifications is shown using the Bruker timsTOF Pro 2.

Our guest speakers Giovanni Rizzato and Anna Moschin from Aquevenete and Waters panel of experts, present the analytical methods we developed to overcome challenges in accordance with the new 2020 EU DWD.

In this presentation you will understand how EAD differs from ETD, CAD and ECD and how each of these techniques have been used to help characterize proteins.

Join Stéphane Dubant, for an overview of how purification in the field of early drug development has evolved.

Measurements of drugs of abuse in blood in a forensic lab require highest reliablity with regard to identification and quantification of the compounds in question.

We are pleased to announce the Plasmion Customer Event 2021, a virtual event covering multiple various areas where SICRIT® technology is successfully adopted and being used.